CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 340 enrolled
Drug / intervention
placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02802241
NCT02802241N/ACompleted
CompareCT.gov

Effects of Open-label vs Double-blind Treatment in IBS.

Beth Israel Deaconess Medical Center·interventional·Posted Jun 16, 2016·Updated Jan 22, 2024

In Brief

A clinical study evaluating placebo and peppermint oil for Irritable Bowel Syndrome and 3 related conditions. Completed, enrolled 340 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIrritable Bowel Syndrome, Placebo Effect, Placebos, Peppermint Oil
CountriesUnited States
CollaboratorsNational Center for Complementary and Integrative Health (NCCIH)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 16, 2016
Enrollment StartJun 1, 2016
Primary CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 10.0 years ago

Interventions

placebodrug

peppermint oildietary